| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.04. | CORDLIFE GROUP LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 09.04. | CORDLIFE GROUP LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 2 | SGX Company Announcements | ||
| 31.03. | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::AUDITOR'S COMMENTS OF ACCOUNTS | 1 | SGX Company Announcements | ||
| 27.02. | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
| 14.01. | Cordlife renews cord blood and human tissue banking licences | 2 | Singapore Business Review | ||
| 14.01. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RENEWAL OF LICENCES | 1 | SGX Company Announcements | ||
| 14.01. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 04.12.25 | Cordlife faces $5.45m in claims over 109 damaged cord blood units | 2 | Singapore Business Review | ||
| CORDLIFE GROUP Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 02.12.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF NON-INDEPENDENT NON-EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 4 | SGX Company Announcements | ||
| 01.12.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RECEIPT OF NOTICE OF REGULATORY ACTION | 2 | SGX Company Announcements | ||
| 27.11.25 | Health ministry suspends Cordlife's blood banking license | 3 | Singapore Business Review | ||
| 27.11.25 | CORDLIFE GROUP LIMITED: REQUEST FOR TRADING HALT::REQUEST FOR TRADING HALT | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: REPL::FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 2 | SGX Company Announcements | ||
| 14.11.25 | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 30.10.25 | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CESSATION OF EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 27.10.25 | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::SUBMISSION OF WRITTEN REPRESENTATIONS TO MOH | 2 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| Q&M DENTAL | - | - | Q & M Dental Full Year Income Drops | ||
| SDI LIMITED | - | - | SDI LIMITED: Change of Director's Interest Notice | ||
| FRESENIUS MEDICAL CARE | 38,690 | 0,00 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FRESENIUS | 44,030 | 0,00 % | FRESENIUS SE & CO KGAA: Struktur in der Ruhe | ||
| BRIGHTSPRING HEALTH SERVICES | 46,010 | -0,07 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,340 | 0,00 % | SIEMENS HEALTHINEERS AG im strategischen Gleichgewicht | ||
| BILLIONTOONE | 80,61 | -2,37 % | BillionToOne, Inc.: BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 | ||
| CARL ZEISS MEDITEC | 27,340 | 0,00 % | EILMELDUNG bei Carl Zeiss Meditec: Das Warnsignal das die meisten Anleger jetzt übersehen - Was ich konkret unternommen habe | ||
| GERRESHEIMER | 17,700 | 0,00 % | Gerresheimer fliegt aus dem SDAX - Shelly Group rückt nach | Die Deutsche Börse nimmt zum 10. April 2026 eine außerplanmäßige Anpassung im SDAX vor. Die Aktie der Gerresheimer AG wird aus dem Index entfernt, weil das Unternehmen die Anforderung zur fristgerechten... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,630 | 0,00 % | Eckert & Ziegler erhält MDR-Zertifizierung für Augentumorbehandlung | Die Eckert & Ziegler BEBIG GmbH, eine auf Brachytherapie spezialisierte Tochtergesellschaft der Eckert & Ziegler SE, hat die MDR-Zertifizierung der EU für ihre Ruthenium-106-Augenapplikatoren erhalten.... ► Artikel lesen | |
| BETA BIONICS | 13,020 | +10,20 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| DRAEGERWERK | 95,70 | 0,00 % | Draegerwerk AG & Co. KGaA: Fokus auf Rentabilität mit klar definiertem Margenverlauf; KAUFEN. | Auf unserer German Select Conference bestätigte Thomas Fischler, der Leiter der Investor Relations von Drägerwerk (Dräger), die strategische Neuausrichtung von Dräger in Richtung Rentabilität, mit dem... ► Artikel lesen | |
| HEARTFLOW | 29,190 | +0,59 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| ESSILORLUXOTTICA | 206,70 | +0,54 % | ANALYSE-FLASH: Goldman senkt Ziel für EssilorLuxottica auf 265 Euro - 'Buy' | NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für EssilorLuxottica von 350 auf 265 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Analyst Richard Felton änderte... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,700 | +4,51 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 |